GM Advisory Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,050
Closed -$222K 194
2021
Q4
$222K Hold
8,050
0.02% 184
2021
Q3
$224K Sell
8,050
-1,450
-15% -$41.1K 0.02% 181
2021
Q2
$279K Sell
9,500
-500
-5% -$15.1K 0.03% 168
2021
Q1
$317K Sell
10,000
-2,000
-17% -$58.7K 0.04% 151
2020
Q4
$249K Sell
12,000
-20,000
-63% -$373K 0.03% 151
2020
Q3
$497K Buy
+32,000
New +$551K 0.08% 95

Other funds holding BHC

GM Advisory Group's BHC Position: Q1 2022 in Review

GM Advisory Group sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 8,050 shares — an estimated $222K sold.

GM Advisory Group first reported a position in BHC in Q3 2020 and held it in 6 quarters. The position peaked at $497K in Q3 2020. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

  • GM Advisory Group reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
  • GM Advisory Group sold 8,050 Bausch Health shares in Q1 2022, an estimated $222K.
  • GM Advisory Group first reported a position in Bausch Health in Q3 2020 and held it in 6 quarters.
  • GM Advisory Group's Bausch Health position peaked at $497K in Q3 2020.
  • 370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on GM Advisory Group's 13F filing for Q1 2022, filed 13 May 2022.